Pachychoroid disease

CMG Cheung, WK Lee, H Koizumi, K Dansingani… - Eye, 2019 - nature.com
Pachychoroid is a relatively novel concept describing a phenotype characterized by
attenuation of the choriocapillaris overlying dilated choroidal veins, and associated with …

Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management

CMG Cheung, TYY Lai, P Ruamviboonsuk, SJ Chen… - Ophthalmology, 2018 - Elsevier
Polypoidal choroidal vasculopathy (PCV) is an age-related macular degeneration (AMD)
subtype and is seen particularly in Asians. Previous studies have suggested disparity in …

EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with …

A Koh, WK Lee, LJ Chen, SJ Chen, Y Hashad, H Kim… - Retina, 2012 - journals.lww.com
Purpose: To assess the effects of verteporfin photodynamic therapy (PDT) combined with
ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic …

Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment

AHC Koh, LJ Chen, SJ Chen, Y Chen, A Giridhar, T Iida… - Retina, 2013 - journals.lww.com
Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy
affecting vision, with clinical features distinct from neovascular age-related macular …

Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?

A Laude, PD Cackett, EN Vithana, IY Yeo… - Progress in retinal and …, 2010 - Elsevier
Neovascular age-related macular degeneration (nAMD) is the commonest cause of severe
visual impairment in older adults in Caucasian white populations. Polypoidal choroidal …

Polypoidal choroidal vasculopathy: a review

Y Imamura, M Engelbert, T Iida, KB Freund… - Survey of …, 2010 - Elsevier
More than a quarter century has passed since the original description of polypoidal
choroidal vasculopathy (PCV) in 1982 as a peculiar hemorrhagic disorder involving the …

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients

F Gomi, M Ohji, K Sayanagi, M Sawa, H Sakaguchi… - Ophthalmology, 2008 - Elsevier
PURPOSE: To determine the prevalence of polypoidal choroidal vasculopathy (PCV) in
Japanese patients presumed to have age-related macular degeneration (AMD) and …

Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results

A Oishi, H Kojima, M Mandai, S Honda… - American journal of …, 2013 - Elsevier
Purpose To compare the effect of photodynamic therapy (PDT) and intravitreal ranibizumab
in patients with polypoidal choroidal vasculopathy (PCV). Design Randomized clinical trial …

Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy

Y Hirami, A Tsujikawa, A Otani, Y Yodoi, H Aikawa… - Retina, 2007 - journals.lww.com
Purpose: To evaluate the clinical features and risk factors of hemorrhagic complications in
eyes with polypoidal choroidal vasculopathy (PCV) after photodynamic therapy (PDT) …

Polypoidal choroidal vasculopathy and treatments

F Gomi, Y Tano - Current opinion in ophthalmology, 2008 - journals.lww.com
Although the polypoidal choroidal vasculopathy and age-related macular degeneration
have been known to share common genetic factors, its clinical characteristics including the …